Skip to main content

Table 2 5-year rates of DMFS by sub-group

From: Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy

Sub-group

Number of patients

5-year DMFS (%)

95% CI

All patients

421

87.8

84.1–91.5

2–3 Intermediate risk factors

104

93.7

88.2–99.2

1 High risk factor

225

88.0

83.1–92.9

2–3 High risk factors

92

81.2

71.6–90.8

V High Risk

126

78.4

70.8–86.0

  1. Abbreviations: CI confidence interval, DMFS distant metastases-free survival